Fact CheckerSign in

NCT07860801Enrolling by invitation

Study of Vaping Use Among Adolescent and Young Adult Patients With Cancer

CLEAR-AYA: Moving Beyond the Clouds - Pilot Study of Vaping Use Among AYA Patients With Cancer

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

The purpose of this study is to learn more about how adolescent and young adult (AYA) cancer patients, their parents and caregivers (referred to as a carebuddy in this study), and their healthcare providers think about and communicate around vaping and tobacco use. The researchers hope this information will help them develop educational materials and provider training tools that are appropriate for young people with cancer. A Community Advisory Board that is made up of AYA patients, parents/caregivers, and healthcare providers, is helping to guide the study. The board will review the materials, give feedback, help the study team understand the findings, and provides input to make sure the study is appropriate and practical for participants.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
80 (estimated)
First submitted
30 Sept 2026
Start date
30 Sept 2026
Primary completion date
30 Sept 2027
Lead sponsor
Memorial Sloan Kettering Cancer Center
NCT number
NCT07860801

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 30 Sept 2026 to the primary completion date, 30 Sept 2027
  • 7 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Acute psychiatric symptoms impairing participation as per the EMR or as per clinician judgment;
  • Reports exclusive use of combustible or smokeless tobacco products (i.e., no history of nicotine vaping).

Other

  • Exclusion criteria for Patients:

Who the study is looking for

  • Inclusion criteria for Patients:
  • History of cancer diagnosis;
  • Report vaping within the past 12 months as documented in the medical record, clinician note, and/or self-report;
  • Age 15-39 years at date of consent;
  • Receiving or have received treatment at MSK;
  • Iidentify English as primary language as per medical record
  • Inclusion criteria for Parents/Carebuddy (i.e., family member, friend):
  • Self-report they are the parent/carebuddy of an AYA patient who currently or previously vaped.
  • Inclusion criteria for Oncology Providers:
  • Conducts ≥2 AYA clinical consultations weekly as per self-report or EMR;
  • Is an MSK clinician (i.e., nurse practitioner, social worker, physician assistant, physician)

Age in the registry: 15 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan Kettering at Basking Ridge (Consent Only)
Coordinator of this site? Confirm its status
Basking RidgeUnited StatesUnknown status
Memorial Sloan Kettering Suffolk - Commack (Consent Only)
Coordinator of this site? Confirm its status
CommackUnited StatesUnknown status
Memorial Sloan Kettering Westchester (Consent only)
Coordinator of this site? Confirm its status
HarrisonUnited StatesUnknown status
Memorial Sloan Kettering Monmouth (Consent Only)
Coordinator of this site? Confirm its status
MiddletownUnited StatesUnknown status
Memorial Sloan Kettering Bergen (Consent Only)
Coordinator of this site? Confirm its status
MontvaleUnited StatesUnknown status
Memorial Sloan Kettering Cancer Center (All Protocol Activites)
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
Memorial Sloan Kettering Nassau (Consent Only)
Coordinator of this site? Confirm its status
UniondaleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.